Dr. Madeleine Blair Chollet, M.D., PH.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 4050 Dublin Blvd, Dublin, CA 94568 Phone: 510-498-2350 |
Dr. Raymond H Hong, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 4050 Dublin Blvd, Dublin, CA 94568 Phone: 510-498-2350 |
News Archive
Omeros Corporation today announced additional positive data in the company's Phase 2 clinical trial of OMS721 for the treatment of thrombotic microangiopathies (TMAs). TMAs are a family of rare, debilitating and life-threatening disorders characterized by excessive thrombi (clots) – aggregations of platelets – in the microcirculation of the body's organs, most commonly the kidney and brain.
Democratic Reps. Henry Waxman (Calif.) and Edward Markey (Mass.) have introduced legislation (HR 1561) that they say would make greater strides toward ensuring the safety of prescription drugs than Senate legislation (S 484) introduced by Sens. Edward Kennedy (D-Mass.) and Mike Enzi (R-Wyo.), CQ HealthBeat reports.
Endo Pharmaceuticals today reported financial results for the first quarter 2010.
Emergent BioSolutions Inc. announced today that it has signed a contract valued at up to $107 million with the Office of the Biomedical Advanced Research and Development Authority (BARDA) of the Department of Health and Human Services (HHS), to develop and obtain regulatory approval for large-scale manufacturing of BioThrax® (Anthrax Vaccine Adsorbed) in Building 55. Building 55 is the company's large-scale state-of-the-art vaccine manufacturing facility in Lansing, Michigan.
› Verified 2 days ago